Baidu
map

CT技术术语及常见病名的中英文对照

2015-02-26 MedSci MedSci原创

A----------abscess of kidney 肾脓肿acoustic 听神经瘤acute pancreatitis 急性胰腺炎analog 模拟analog/digital converter 模拟/数字转化器angiography of spinal cord 脊髓血管造影angioma 血管瘤angiomyolipoma 血管平滑肌脂肪瘤anterior cerebral ar

A
----------
abscess of kidney 肾脓肿
acoustic 听神经瘤
acute pancreatitis 急性胰腺炎
analog 模拟
analog/digital converter 模拟/数字转化器
angiography of spinal cord 脊髓血管造影
angioma 血管瘤
angiomyolipoma 血管平滑肌脂肪瘤
anterior cerebral artery,ACA 大脑前动脉
anterior communicating artery,AcoA 前交通动脉
arachnoidcyst 蛛网膜囊肿
arterior-venous malformation,AVM 动静脉畸形
artifact 伪影
astrocytoma 星形细胞瘤
atelectasis 肺不张
attenuation 衰减
attenuation coefficient 衰减系数
axial scan 轴位扫描

B
----------
B basilar artery,BA 基底动脉
Beam hardening artifact 射线硬化伪影
biopsy gun 活检枪
biopsy needle 活检针
biphasic contrast enhancement 双期增强扫描
bone mineral density,BMD 骨密度
brain abscess 脑脓肿
brain hemorrhage 脑出血
brain trauma 脑外伤
bronchiectsis 支气管扩张
bronchogenic carcinoma 支气管肺癌

C
----------
calcification of the pleura 胸膜钙化
calculus of kidney 肾结石
carcinoma of bladder 膀胱癌
carcinoma of the cervix 宫颈癌
carcinoma of kidney 肾癌
carcinoma of prostate 前列腺癌
carcinoma of ovary 卵巢癌
cavity 空洞
central bronchogenic carcinoma 中央型肺癌
cerebral atrophy 脑萎缩
cerebral contusion 脑搓伤
cerebral infarction 脑梗塞
cerebral ischemia 脑缺血
cerebral cycticercosis 脑囊虫病
cholesteatoma 胆脂瘤
cholangiocarcinoma 胆管癌
cholecystitis 胆囊炎
chronic pancreatitis 慢性胰腺炎
circle of willis 脑底动脉环
cirrhosis 肝硬化
collimator 准直器
console 控制台
contrast medium 对比剂
contrast enhancement 对比增强
contrast media bolus 造影剂团注
contusion of kidney 肾挫伤
contusion of spinal cord 脊髓挫伤
coronal scan 冠状面扫描
craniopharyngioma 颅咽管瘤
CT angiography,CTA CT血管造影术
CT arterial portography,CTAP CT动脉性门脉造影
CT fluoroscopy CT透视
CT guided needle biopsy CT导向穿刺活检
CT guided fine needle aspiration biopsy CT导向细针抽吸活组织检查
CT guided stereotaxis CT导向立体定位
CT intervention CT介入
CT muelography,CTM CT脊髓造影
CT value CT值
Cyst of Kinney 肾囊肿

D
----------
delayed scan 延迟扫描
density resolution 密度分辨率
digital martrix 数字矩阵
dynamic scanning 动态扫描

E
----------
enhancement scan 增强扫描
ependymoma 室管膜瘤
epidural hematoma 硬膜外血肿

F
----------
fatty liver 脂肪肝
field of view,FOV 视野
FWHM 有效层厚

G
----------
gallbladder carcinoma 胆囊癌
gallstone 胆石症
golima 胶质瘤
Graves’ disease 格氏眼病
H
----------
hepatic cyst 肝囊肿
hepatocellular 肝细胞癌
high KV radiography 高千伏摄影
high resolution CT,HRCT 高分辨率CT
high spatial-freqyency algorithm 高空间频率计算法重建
hypaque 泛影钠

I
----------
image post-processing 图象后处理
image reconstruction 图象重建
informatics in radiology,infoRAD 信息放射学
interventional radiology 介入放射学
iodipamide/biligrafin/cholografin 胆影葡胺
iohexol 碘苯六醇(欧乃派克)
iopromide 碘普罗胺
isovist 伊索显

L
----------
laser printer 激光打印机

M
----------
matrix 矩阵
maximum intensity projection,MIP 最大强度投影
medulloblastoma 髓母细胞瘤
meningioma 黑色素瘤
motion artifact 运动伪影
multiformat camera 多幅相机
multiplanar reformation,MPR 多平面重建
multiple sclerosis 多发性肝硬化

N
----------
neurofibroma 神经纤维瘤
noise 噪声

O
----------
orbitomeatal line 听眶线
overlap scan 重叠扫描

P
----------
partial volume effect 部分容积效应
peripheral space phenomenon 周围间隙现象
picture achieve and communication system,PACS 图象存储和传输系统
pitch 螺距
pixel 像素
plain scan 平扫
pleural effusion 胸腔积液
posterior cerebral artery,PCA 大脑后动脉
preventive maintenace 日常维护程序
protrusion of intervertebral disk 椎间盘突出

Q
----------
quantitative computed tomography,QCT 定量CT

R
----------
region of interest 兴趣区
retinoblastoma 视网膜母细胞瘤

S
----------
scout view 定位扫描
slice increment 间距
slice thickness 层厚
spatial resolution 空间分辨率
spinal srenosis 椎管狭窄
spiral CT/helical CT 螺旋CT
subdural hematoma 硬膜下血肿

T
----------
teleradiology 远程放射学
temporal resolution 时间分辨率
thin slice scan 薄层扫描
three dimension computed tomography,3 DCT 三维CT
three-dimensional surface reconstrction,SSD 三维表面重建
threshold 阈值
tomography 体层摄影
tuberculosis 肺结核

U
----------
ultrafast CT,UFCT 超高速CT
ultravist 优维显
urografin 泛影葡胺

V
----------
vertebral artery,VA 椎动脉
virtual endoscopy,VE 仿真内镜
volume acquisition 容积采集
volume scan 容积扫描
voxel matrix 像素矩阵

W
----------
window level 窗位
window width 窗宽
work station 工作站

X
----------
Xeroradiography 干板照相
X-ray tube X线球管
Xenon,Xe 氙气

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1775286, encodeId=418d1e75286ff, content=<a href='/topic/show?id=937d46650bf' target=_blank style='color:#2F92EE;'>#对照#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46650, encryptionId=937d46650bf, topicName=对照)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ae138776909, createdName=amyloid, createdTime=Fri Mar 06 07:19:00 CST 2015, time=2015-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2054598, encodeId=8dec2054598a0, content=<a href='/topic/show?id=020b48642a9' target=_blank style='color:#2F92EE;'>#常见病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48642, encryptionId=020b48642a9, topicName=常见病)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/pSGl6CJeZ2PzWxdhCtrvv4U9Q281RV8e0AKmlB5ib93DibbiaRyOzmkCdz5F04cbfX5RGOpG4dOXvuQW1fumibVeBg/132, createdBy=fc342500110, createdName=ms9833124466084992, createdTime=Wed Jan 13 17:19:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18620, encodeId=2b0618620ea, content=很好,学习中, beContent=null, objectType=article, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=97941618541, createdName=feige82, createdTime=Sun Mar 22 09:17:00 CST 2015, time=2015-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18567, encodeId=27041856ed1, content=涨姿势了,学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7bf41618580, createdName=biluodaofeng, createdTime=Fri Mar 20 18:23:00 CST 2015, time=2015-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17220, encodeId=1f541e2206b, content=不错的文章,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=36a81612921, createdName=xiaoai5777, createdTime=Sat Feb 28 11:03:00 CST 2015, time=2015-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1616454, encodeId=a42f1616454ff, content=<a href='/topic/show?id=5ade6111973' target=_blank style='color:#2F92EE;'>#术语#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61119, encryptionId=5ade6111973, topicName=术语)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9d519759190, createdName=ms49895894946433513521, createdTime=Sat Feb 28 07:19:00 CST 2015, time=2015-02-28, status=1, ipAttribution=)]
    2015-03-06 amyloid
  2. [GetPortalCommentsPageByObjectIdResponse(id=1775286, encodeId=418d1e75286ff, content=<a href='/topic/show?id=937d46650bf' target=_blank style='color:#2F92EE;'>#对照#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46650, encryptionId=937d46650bf, topicName=对照)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ae138776909, createdName=amyloid, createdTime=Fri Mar 06 07:19:00 CST 2015, time=2015-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2054598, encodeId=8dec2054598a0, content=<a href='/topic/show?id=020b48642a9' target=_blank style='color:#2F92EE;'>#常见病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48642, encryptionId=020b48642a9, topicName=常见病)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/pSGl6CJeZ2PzWxdhCtrvv4U9Q281RV8e0AKmlB5ib93DibbiaRyOzmkCdz5F04cbfX5RGOpG4dOXvuQW1fumibVeBg/132, createdBy=fc342500110, createdName=ms9833124466084992, createdTime=Wed Jan 13 17:19:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18620, encodeId=2b0618620ea, content=很好,学习中, beContent=null, objectType=article, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=97941618541, createdName=feige82, createdTime=Sun Mar 22 09:17:00 CST 2015, time=2015-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18567, encodeId=27041856ed1, content=涨姿势了,学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7bf41618580, createdName=biluodaofeng, createdTime=Fri Mar 20 18:23:00 CST 2015, time=2015-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17220, encodeId=1f541e2206b, content=不错的文章,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=36a81612921, createdName=xiaoai5777, createdTime=Sat Feb 28 11:03:00 CST 2015, time=2015-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1616454, encodeId=a42f1616454ff, content=<a href='/topic/show?id=5ade6111973' target=_blank style='color:#2F92EE;'>#术语#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61119, encryptionId=5ade6111973, topicName=术语)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9d519759190, createdName=ms49895894946433513521, createdTime=Sat Feb 28 07:19:00 CST 2015, time=2015-02-28, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1775286, encodeId=418d1e75286ff, content=<a href='/topic/show?id=937d46650bf' target=_blank style='color:#2F92EE;'>#对照#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46650, encryptionId=937d46650bf, topicName=对照)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ae138776909, createdName=amyloid, createdTime=Fri Mar 06 07:19:00 CST 2015, time=2015-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2054598, encodeId=8dec2054598a0, content=<a href='/topic/show?id=020b48642a9' target=_blank style='color:#2F92EE;'>#常见病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48642, encryptionId=020b48642a9, topicName=常见病)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/pSGl6CJeZ2PzWxdhCtrvv4U9Q281RV8e0AKmlB5ib93DibbiaRyOzmkCdz5F04cbfX5RGOpG4dOXvuQW1fumibVeBg/132, createdBy=fc342500110, createdName=ms9833124466084992, createdTime=Wed Jan 13 17:19:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18620, encodeId=2b0618620ea, content=很好,学习中, beContent=null, objectType=article, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=97941618541, createdName=feige82, createdTime=Sun Mar 22 09:17:00 CST 2015, time=2015-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18567, encodeId=27041856ed1, content=涨姿势了,学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7bf41618580, createdName=biluodaofeng, createdTime=Fri Mar 20 18:23:00 CST 2015, time=2015-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17220, encodeId=1f541e2206b, content=不错的文章,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=36a81612921, createdName=xiaoai5777, createdTime=Sat Feb 28 11:03:00 CST 2015, time=2015-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1616454, encodeId=a42f1616454ff, content=<a href='/topic/show?id=5ade6111973' target=_blank style='color:#2F92EE;'>#术语#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61119, encryptionId=5ade6111973, topicName=术语)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9d519759190, createdName=ms49895894946433513521, createdTime=Sat Feb 28 07:19:00 CST 2015, time=2015-02-28, status=1, ipAttribution=)]
    2015-03-22 feige82

    很好,学习中

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1775286, encodeId=418d1e75286ff, content=<a href='/topic/show?id=937d46650bf' target=_blank style='color:#2F92EE;'>#对照#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46650, encryptionId=937d46650bf, topicName=对照)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ae138776909, createdName=amyloid, createdTime=Fri Mar 06 07:19:00 CST 2015, time=2015-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2054598, encodeId=8dec2054598a0, content=<a href='/topic/show?id=020b48642a9' target=_blank style='color:#2F92EE;'>#常见病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48642, encryptionId=020b48642a9, topicName=常见病)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/pSGl6CJeZ2PzWxdhCtrvv4U9Q281RV8e0AKmlB5ib93DibbiaRyOzmkCdz5F04cbfX5RGOpG4dOXvuQW1fumibVeBg/132, createdBy=fc342500110, createdName=ms9833124466084992, createdTime=Wed Jan 13 17:19:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18620, encodeId=2b0618620ea, content=很好,学习中, beContent=null, objectType=article, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=97941618541, createdName=feige82, createdTime=Sun Mar 22 09:17:00 CST 2015, time=2015-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18567, encodeId=27041856ed1, content=涨姿势了,学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7bf41618580, createdName=biluodaofeng, createdTime=Fri Mar 20 18:23:00 CST 2015, time=2015-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17220, encodeId=1f541e2206b, content=不错的文章,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=36a81612921, createdName=xiaoai5777, createdTime=Sat Feb 28 11:03:00 CST 2015, time=2015-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1616454, encodeId=a42f1616454ff, content=<a href='/topic/show?id=5ade6111973' target=_blank style='color:#2F92EE;'>#术语#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61119, encryptionId=5ade6111973, topicName=术语)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9d519759190, createdName=ms49895894946433513521, createdTime=Sat Feb 28 07:19:00 CST 2015, time=2015-02-28, status=1, ipAttribution=)]
    2015-03-20 biluodaofeng

    涨姿势了,学习了!

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1775286, encodeId=418d1e75286ff, content=<a href='/topic/show?id=937d46650bf' target=_blank style='color:#2F92EE;'>#对照#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46650, encryptionId=937d46650bf, topicName=对照)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ae138776909, createdName=amyloid, createdTime=Fri Mar 06 07:19:00 CST 2015, time=2015-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2054598, encodeId=8dec2054598a0, content=<a href='/topic/show?id=020b48642a9' target=_blank style='color:#2F92EE;'>#常见病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48642, encryptionId=020b48642a9, topicName=常见病)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/pSGl6CJeZ2PzWxdhCtrvv4U9Q281RV8e0AKmlB5ib93DibbiaRyOzmkCdz5F04cbfX5RGOpG4dOXvuQW1fumibVeBg/132, createdBy=fc342500110, createdName=ms9833124466084992, createdTime=Wed Jan 13 17:19:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18620, encodeId=2b0618620ea, content=很好,学习中, beContent=null, objectType=article, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=97941618541, createdName=feige82, createdTime=Sun Mar 22 09:17:00 CST 2015, time=2015-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18567, encodeId=27041856ed1, content=涨姿势了,学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7bf41618580, createdName=biluodaofeng, createdTime=Fri Mar 20 18:23:00 CST 2015, time=2015-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17220, encodeId=1f541e2206b, content=不错的文章,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=36a81612921, createdName=xiaoai5777, createdTime=Sat Feb 28 11:03:00 CST 2015, time=2015-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1616454, encodeId=a42f1616454ff, content=<a href='/topic/show?id=5ade6111973' target=_blank style='color:#2F92EE;'>#术语#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61119, encryptionId=5ade6111973, topicName=术语)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9d519759190, createdName=ms49895894946433513521, createdTime=Sat Feb 28 07:19:00 CST 2015, time=2015-02-28, status=1, ipAttribution=)]
    2015-02-28 xiaoai5777

    不错的文章,学习了

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1775286, encodeId=418d1e75286ff, content=<a href='/topic/show?id=937d46650bf' target=_blank style='color:#2F92EE;'>#对照#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46650, encryptionId=937d46650bf, topicName=对照)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ae138776909, createdName=amyloid, createdTime=Fri Mar 06 07:19:00 CST 2015, time=2015-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2054598, encodeId=8dec2054598a0, content=<a href='/topic/show?id=020b48642a9' target=_blank style='color:#2F92EE;'>#常见病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48642, encryptionId=020b48642a9, topicName=常见病)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/pSGl6CJeZ2PzWxdhCtrvv4U9Q281RV8e0AKmlB5ib93DibbiaRyOzmkCdz5F04cbfX5RGOpG4dOXvuQW1fumibVeBg/132, createdBy=fc342500110, createdName=ms9833124466084992, createdTime=Wed Jan 13 17:19:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18620, encodeId=2b0618620ea, content=很好,学习中, beContent=null, objectType=article, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=97941618541, createdName=feige82, createdTime=Sun Mar 22 09:17:00 CST 2015, time=2015-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18567, encodeId=27041856ed1, content=涨姿势了,学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7bf41618580, createdName=biluodaofeng, createdTime=Fri Mar 20 18:23:00 CST 2015, time=2015-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17220, encodeId=1f541e2206b, content=不错的文章,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=36a81612921, createdName=xiaoai5777, createdTime=Sat Feb 28 11:03:00 CST 2015, time=2015-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1616454, encodeId=a42f1616454ff, content=<a href='/topic/show?id=5ade6111973' target=_blank style='color:#2F92EE;'>#术语#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61119, encryptionId=5ade6111973, topicName=术语)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9d519759190, createdName=ms49895894946433513521, createdTime=Sat Feb 28 07:19:00 CST 2015, time=2015-02-28, status=1, ipAttribution=)]

相关资讯

腰椎间盘突出CT和MRI读片技巧

椎间盘突出症是一种多发病,要确诊自己是否患有腰椎间盘突出症,最好的方法是去医院拍一张腰部CT片或者MRI(磁共振片子)。 不过一般医生都没有充裕的时间把片子报告详细解释给你听,患者常常只能拿着“语言简练”的CT或者磁共振报告单对自己的病情似懂非懂。 不要着急~现在就来手把手教你,怎样自己也能看懂CT和MRI磁共振片子,做到自己心中有数。学习本看片教程不需要以前有医学知识背景,只

JAMA:常规CEA和CT联合检查结直肠癌复发无优势

研究要点: 1、常规CEA 和 CT随访3至5年检查结直肠癌复发; 2、CEA与CT联合检查无优势。即使某一种检查方案有生存优势,效果也非常有限。 结直肠癌术后强化随访是常见临床实践之一,但其证据基础还很缺乏。本研究旨在评估血液癌胚抗原 (CEA)常规检测和CT随访检查结直肠癌根治术后复发率的有效性。【原文下载】 各随机分组诊断至复发的时间间隔 该项随机临

高分辨率CT对慢性化脓性中耳炎术式选择的临床价值

近日,中山大学附属第一医院耳鼻咽喉科医院耳鼻咽喉科学研究所研究人员发表论文,旨在探讨颞骨高分辨率CT(HRCT)对慢性化脓性中耳炎术前病变评估及术式选择的临床价值。 研究指出,颞骨HRCT检查对慢性化脓性中耳炎术式选择、手术入路和病灶清除及手术的安全性有重要参考价值,对上鼓室鼓窦病变性质、听骨链破坏评估的准确性存在一定局限性,随着中耳病变加重并出现骨质破坏,准确性相应增加。该文发表在2013年第

临床上CT、MRI、PET三种检查的比较

CT(X线电子计算机断层扫描)主要是利用X线断层扫描,电光子探测器接收,并把信号转化为数字输入电子计算机,再由计算机转化为图像,是一种无痛苦、无损伤的辅助检查工具。CT的特点:具有检查方便、安全、无痛苦、无创伤的特点。图像清晰、分辩力高、解剖关系明确、病态显影清楚。与MRI比较起来,CT的优点主要在于对骨性疾病、早期脑出血的显示优于MRI,同时成像速度快,器官的运动伪影较小,CT的优势还在对肺部、

Stroke:MRI灌注成像与CTc可交替使用

一项最新研究表明,检测卒中患者急性梗塞病灶时,MRI灌注成像(MRP)和CT灌注成像(CTP)可交替使用。在不同的灌注成像时,研究者发现残余功能的达峰时间(Tmax)是唯一在两种成像技术中均无统计学差异的灌注缺损指标。【原文下载】 夏洛茨维尔弗吉尼亚大学医疗中心神经放射学主席Max Wintermark医生说,“我认为这篇文章是十分重要的,因为不管是使用哪种检测方式,你都能得到几乎完全一致的

三维CT技术有助提高脊椎手术成功率

美国医疗人员最新研究表明,一种新型手术导航技术有助于提高脊椎重建手术的成功率,并可减少相关并发症状。 脊椎重建术通过植入支架或置换人工椎间盘等手段,治疗严重脊椎疾病或脊椎退化。目前这一手术主要采用X射线观察脊柱图像,指导医生操作。由于这一传统技术只能提供二维画面,不易精确定位,因此只要出现一点偏差就可能导致手术器械错位,需要进行额外手术,并可能诱发并发症。 洛杉矶锡达斯—赛奈医疗中心的外科医生

Baidu
map
Baidu
map
Baidu
map